The FDA's usual end-of-year flurry of regulatory approvals is a little lighter than usual, but the agency has delivered some end-of-year cheer to Vanda Pharma after giving the go-ahead to its drug for ...
This condition, called hyperemesis gravidarum, can last the whole pregnancy and be dangerous for both the woman and the fetus ...
Until about five years ago, scientists believed the pregnancy hormone, human chorionic gonadotropin (hCG), was the culprit.
A combination of physiological, neurological, genetic, and habit-linked factors influences how prone one is to feeling motion ...
Some people have guts of steel, while others are … a little more sensitive. Here are tips for preventing stomach discomfort ...
The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...
My voyage was rough and I experienced a significant Drake Shake. Fortunately, I managed to avoid any significant seasickness, ...
The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion in adults, Vanda Pharmaceuticals announced Tuesday. The approval marks the ...
Does motion sickness turn you into a green, spewing mess? For plenty of people, the answer is yes. Current remedies may or ...
Analysts raise price targets for Vanda Pharmaceuticals after FDA approved a motion sickness drug, citing growth potential.
In today’s ACT Brief, we explore how site initiation can be leveraged to improve early trial performance through demonstrated ...
In today’s Pharmaceutical Executive Daily, the Wegovy Pill becomes the first available oral GLP-1 for weight management, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback